JPRN-UMIN000012971已完成1 期
Phase I study of intraperitoneal docetaxel combined with capecitabine plus cisplatin for advanced gastric cancer with peritoneal metastasis - Phase I study of XP+IP DOC
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Other active concomitant malignancies, massive ascites or other severe medical conditions.
研究者
相似试验
已完成
2 期
Phase II study of intraperitoneal docetaxel combined with capecitabine plus cisplatin for advanced gastric cancer with peritoneal metastasisgastric cancer with peritoneal metastasisJPRN-UMIN000016469The University of Tokyo50
已完成
不适用
A phase I trial of intraperitoneal docetaxel and cisplatin with S-1 for treatment of gastric cancer with peritoneal disseminatiogastric cancer with periotoneal metastasisJPRN-UMIN000021376Department of Gastroenterologic Surgery, Kanazawa Universiy30
已完成
1 期
Phase I study of intraperitoneal docetaxel and irinotecan for advanced gastric cancer with peritoneal metastasisgastric cancer with peritoneal metastasisJPRN-UMIN000017084The University of Tokyo12
已完成
不适用
Phase I/II study of the combination of docetaxel, CDDP and S-1 in patients with unresectable advanced gastric cancerunresectable advanced gastric cancerJPRN-C000000080Fourth Department of Internal Medicine, Sapporo Medical University40
终止
1 期
Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal CarcinomatosisPeritoneal CarcinomatosisNCT04583488Johns Hopkins University2